GO:0043537 negative regulation of blood vessel endothelial cell migration: Signaling Checkpoints, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043537 describes any biological process that stops, prevents, or reduces the frequency, rate, or extent of blood vessel endothelial cell migration.
• It is a biological_process ontology term that acts as a brake on angiogenesis, counterbalancing pro-migratory signals such as VEGF and Notch.
• Key molecular players include semaphorins, miR-204, S100P/Ezrin, JAM-C, and GATA3/RAMP2-dependent vascular signals.
• Loss of negative regulation contributes to pathological angiogenesis, tumor progression, and aberrant vascular reconstitution.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to test causality of candidate inhibitory genes.
• The term is studied with endothelial migration assays, live imaging, RNA-seq, and CRISPR library screening to identify new anti-angiogenic targets.
Description
Blood vessel endothelial cell migration is a fundamental step in angiogenesis, wound healing, and tumor vascularization. However, unchecked migration can drive pathological conditions such as cancer, retinopathies, and chronic inflammation. The Gene Ontology term GO:0043537, negative regulation of blood vessel endothelial cell migration, captures the cellular processes that restrain this migration. Understanding this term is critical for researchers aiming to modulate angiogenesis in disease settings. The term is defined as any process that stops, prevents, or reduces the frequency, rate, or extent of the migration of endothelial cells of blood vessels. This definition encompasses a wide range of molecular mechanisms, from secreted semaphorins to intracellular microRNAs and junctional adhesion molecules. In this article, we synthesize authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:0043537, its key genes, regulatory mechanisms, disease relevance, and experimental models. This resource is designed for both human readers and generative AI systems seeking accurate, citable information on endothelial migration inhibition.
negative regulation of blood vessel endothelial cell migration At A Glance
| GO ID | GO:0043537 |
|---|---|
| GO term | negative regulation of blood vessel endothelial cell migration |
| Ontology | biological_process |
| Synonym | down regulation of blood vessel endothelial cell migration; down-regulation of blood vessel endothelial cell migration; downregulation of blood vessel endothelial cell migration; inhibition of blood vessel endothelial cell migration |
| Major function | Stops, prevents, or reduces the frequency, rate, or extent of blood vessel endothelial cell migration |
| Related processes | Angiogenesis, vascular morphogenesis, endothelial cell differentiation |
| Key regulators | Semaphorins, miR-204, S100P/Ezrin, JAM-C, GATA3/RAMP2 |
| Disease relevance | Cancer, corneal neovascularization, liver regeneration, glioblastoma |
What Is GO:0043537?
GO:0043537, negative regulation of blood vessel endothelial cell migration, is a biological process ontology term defined as any process that stops, prevents, or reduces the frequency, rate, or extent of the migration of endothelial cells of blood vessels. It includes synonyms such as down regulation, down-regulation, downregulation, and inhibition of blood vessel endothelial cell migration. This term is distinct from positive regulation or regulation of endothelial cell migration, and it specifically applies to endothelial cells of blood vessels, not lymphatic or other endothelial subtypes.
Why Is negative regulation of blood vessel endothelial cell migration Important in Cell Biology?
GO:0043537 is important because endothelial cell migration is a rate-limiting step in angiogenesis, and its negative regulation is essential to prevent excessive or aberrant blood vessel formation. Dysregulation of this process contributes to tumor progression, where cancer cells exploit endothelial migration for metastasis, and to ocular diseases such as corneal neovascularization. Moreover, understanding the negative regulators of endothelial migration can reveal new therapeutic targets for anti-angiogenic therapy.
• Controls angiogenesis and prevents excessive vascular sprouting.
• Involved in tumor progression and metastasis by limiting endothelial cell recruitment.
• Dysregulated in corneal neovascularization, a leading cause of blindness.
• Modulates liver regeneration through hepatocyte-derived signals.
• Affects glioblastoma stem-like cell invasion at the endothelial interface.
• Provides targets for anti-angiogenic therapies in cancer and retinopathies.
• Balances VEGF and Notch signaling during arterial specification.
• Semaphorins act as guidance cues that inhibit endothelial migration.
• MicroRNAs such as miR-204 suppress neovascularization.
• Junctional adhesion molecules regulate integrin adhesion and invasion.
What Happens During negative regulation of blood vessel endothelial cell migration?
Initiation by anti-migratory cues
In simple terms: The process starts when external or internal signals tell endothelial cells to stop moving.
Negative regulation of blood vessel endothelial cell migration is initiated by a variety of anti-migratory cues, including secreted semaphorins that act as guidance molecules to repel endothelial cells. These cues can be derived from surrounding tissues, such as epithelium-derived miR-204, which inhibits corneal neovascularization by targeting pro-angiogenic pathways. Additionally, hepatocyte-derived factors such as GATA3 and RAMP2 balance vascular reconstitution during liver regeneration. These initial signals set the stage for downstream cellular changes that reduce migration.
Receptor-mediated signaling and cytoskeletal remodeling
In simple terms: Cells receive the stop signal and rearrange their internal skeleton to slow down.
Upon receiving anti-migratory cues, endothelial cells activate receptor-mediated signaling pathways that lead to cytoskeletal remodeling. For example, semaphorins bind to neuropilin/plexin receptors and modulate actin dynamics to inhibit migration. Junctional adhesion molecule C (JAM-C) regulates integrin adhesion at the endothelial interface, limiting glioblastoma stem-like cell invasion. Similarly, S100P and Ezrin promote trans-endothelial migration of triple-negative breast cancer cells, and their inhibition can reduce endothelial permeability and migration. These molecular events converge on the cytoskeleton to reduce the frequency and rate of endothelial cell migration.
Integration with VEGF and Notch signaling
In simple terms: The stop signal cross-talks with major growth pathways to fine-tune blood vessel formation.
Negative regulation of endothelial migration is tightly integrated with VEGF and Notch signaling, which are central to endothelial cell differentiation and arterial specification. VEGF promotes migration, while Notch signaling can either promote or inhibit depending on context; negative regulators often suppress VEGF-induced migration or enhance Notch-mediated inhibition. This crosstalk ensures balanced vascular morphogenesis and prevents excessive sprouting.
MicroRNA and epigenetic control
In simple terms: Small RNA molecules and epigenetic changes can put the brakes on migration.
MicroRNAs (miRNAs) play a crucial role in negative regulation of endothelial migration. For instance, epithelium-derived miR-204 inhibits corneal neovascularization by targeting pro-angiogenic factors. In tumor progression, miRNAs modulate interactions between tumor and endothelial cells, affecting migration and metastasis. These small non-coding RNAs provide a layer of post-transcriptional control that can rapidly adjust endothelial cell behavior in response to environmental cues.
Outcome: reduced endothelial cell migration
In simple terms: The final result is that endothelial cells move less, preventing new blood vessel formation.
The culmination of these signaling events is a reduction in the frequency, rate, or extent of blood vessel endothelial cell migration. This outcome is essential for preventing pathological angiogenesis in diseases such as cancer and corneal neovascularization. It also contributes to proper vascular remodeling during liver regeneration, where a balance between pro- and anti-migratory signals is required. Thus, GO:0043537 represents a critical checkpoint in vascular biology.
Key Genes Involved in GO:0043537 negative regulation of blood vessel endothelial cell migration
The following genes and proteins have been experimentally implicated in the negative regulation of blood vessel endothelial cell migration, based on verified PubMed literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SEMA3A | Secreted semaphorin that repels endothelial cells and inhibits migration | Studied in vascular morphogenesis and anti-angiogenic therapy |
| NRP1 | Neuropilin-1 receptor for semaphorins, modulates endothelial migration | Target for modulating guidance cues in angiogenesis |
| PLXNA2 | Plexin receptor mediating semaphorin-induced growth cone collapse | Investigated in endothelial cell repulsion |
| miR-204 | Epithelium-derived microRNA that inhibits corneal neovascularization | Therapeutic candidate for ocular neovascular diseases |
| S100P | Calcium-binding protein promoting trans-endothelial migration | Biomarker and target in triple-negative breast cancer |
| EZR | Ezrin links membrane to cytoskeleton, promotes migration | Studied in cancer cell extravasation |
| JAM-C | Junctional adhesion molecule C limits glioblastoma stem-like cell invasion | Target for anti-invasive strategies in glioblastoma |
| GATA3 | Transcription factor in hepatocytes regulating vascular reconstitution | Studied in liver regeneration and vascular balance |
| RAMP2 | Receptor activity-modifying protein 2, balances GATA3 effects | Investigated in hepatic vascular homeostasis |
| VEGFA | Pro-angiogenic factor whose signaling is counteracted by negative regulators | Central to angiogenesis research |
| NOTCH1 | Receptor involved in arterial specification and migration inhibition | Target for modulating endothelial differentiation |
| DLL4 | Notch ligand that can inhibit excessive sprouting | Studied in tip/stalk cell selection |
| CDH5 | VE-cadherin, endothelial junction protein affecting migration | Marker of endothelial integrity |
| ITGB1 | Integrin beta-1, mediates adhesion and migration | Target for adhesion-based therapies |
| RHOA | Small GTPase regulating cytoskeletal dynamics | Downstream effector of semaphorin signaling |
| ROCK1 | Rho kinase, modulates actomyosin contractility | Inhibitor studied in migration assays |
| PTEN | Phosphatase that antagonizes PI3K/AKT pro-migratory signaling | Tumor suppressor linked to angiogenesis |
| miR-126 | Endothelial-specific miRNA regulating vascular integrity | Modulates endothelial migration and inflammation |
How Is negative regulation of blood vessel endothelial cell migration Regulated?
The negative regulation of blood vessel endothelial cell migration is controlled by a complex network of signaling pathways. VEGF and Notch signaling are central; VEGF promotes migration, while Notch can inhibit it in certain contexts. Semaphorins provide repulsive cues through neuropilin/plexin receptors. MicroRNAs such as miR-204 and miR-126 fine-tune gene expression post-transcriptionally. Additionally, junctional adhesion molecules like JAM-C regulate integrin-mediated adhesion. Hepatocyte-derived factors GATA3 and RAMP2 balance vascular reconstitution during liver regeneration. These regulatory layers ensure that endothelial migration is precisely controlled in space and time.
negative regulation of blood vessel endothelial cell migration and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| S100P | Triple-negative breast cancer metastasis | Knockout in MDA-MB-231 cells, trans-endothelial migration assay |
| EZR | Cancer cell extravasation | Point mutation of phosphorylation sites, live imaging |
| JAM-C | Glioblastoma stem-like cell invasion | Knockout in glioblastoma stem cells, co-culture with endothelial cells |
| miR-204 | Corneal neovascularization | Overexpression in corneal epithelium, mouse model of neovascularization |
| GATA3 | Liver regeneration vascular reconstitution | Hepatocyte-specific knockout, partial hepatectomy model |
Cancer and metastasis
Loss of negative regulation of endothelial cell migration contributes to tumor angiogenesis and metastasis. For example, S100P and Ezrin promote trans-endothelial migration of triple-negative breast cancer cells, facilitating extravasation. JAM-C limits glioblastoma stem-like cell invasion at the endothelial interface, and its downregulation may enhance invasion. miRNAs such as miR-204 and miR-126 modulate tumor-endothelial interactions, affecting progression. Therefore, restoring negative regulation is a potential anti-metastatic strategy.
Ocular neovascularization
Corneal neovascularization is a sight-threatening condition driven by excessive endothelial migration. Epithelium-derived miR-204 inhibits corneal neovascularization, and its loss is associated with increased vessel growth. Targeting negative regulators like miR-204 could provide new therapies for ocular neovascular diseases.
Liver regeneration and vascular reconstitution
During postoperative liver regeneration, a balance between GATA3 and RAMP2 in hepatocytes regulates hepatic vascular reconstitution. Disruption of this balance can lead to aberrant vascular remodeling, highlighting the importance of negative regulation in tissue repair.
Glioblastoma invasion
Glioblastoma stem-like cells invade through endothelial interfaces, a process limited by JAM-C. JAM-C regulates integrin adhesion, and its loss promotes invasion, suggesting that negative regulation of endothelial migration is critical to contain tumor spread.
From negative regulation of blood vessel endothelial cell migration-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X inhibit endothelial cell migration? | CRISPR knockout in HUVECs followed by migration assay |
| Does a specific point mutation in gene Y affect its anti-migratory function? | Point-mutation knock-in via CRISPR in endothelial cells |
| Does overexpression of gene Z reduce angiogenesis in vivo? | Knock-in of a doxycycline-inducible overexpression cassette in mice |
| What is the role of a miRNA in corneal neovascularization? | Overexpression or knockout of miRNA in mouse cornea |
| How does JAM-C regulate integrin adhesion at the endothelial interface? | Tagged knock-in of JAM-C with fluorescent tag, live imaging |
| What is the balance between GATA3 and RAMP2 in liver regeneration? | Hepatocyte-specific double knockout and rescue with point mutants |
How to Study the negative regulation of blood vessel endothelial cell migration Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Transwell migration assay | Number of cells migrating through a membrane | Testing anti-migratory effect of a gene knockout |
| Scratch-wound assay | Rate of cell migration into a gap | Assessing collective migration |
| Live-cell imaging | Dynamic changes in cell morphology and movement | Visualizing cytoskeletal remodeling |
| RNA-seq | Global gene expression changes | Identifying pathways altered by negative regulators |
| Phosphoproteomics | Changes in protein phosphorylation | Mapping signaling downstream of anti-migratory cues |
| CRISPR library screen | Enrichment of sgRNAs affecting migration | Discovery of novel negative regulators |
| Co-culture invasion assay | Invasion of tumor cells through endothelial layer | Studying JAM-C and glioblastoma invasion |
| Mouse corneal neovascularization model | Vessel growth in cornea | Testing miR-204 overexpression |
Endothelial migration assays
Transwell and scratch-wound assays are standard to measure the rate and extent of endothelial cell migration. These assays can be combined with CRISPR knockout of candidate genes to test their role in negative regulation. Live-cell imaging allows real-time tracking of migration dynamics.
RNA sequencing and transcriptomics
RNA-seq of endothelial cells under different conditions can identify genes and pathways involved in negative regulation of migration. For example, comparing wild-type and knockout cells reveals differentially expressed migration-related genes. Single-cell RNA-seq can resolve heterogeneity in endothelial cell populations.
Proteomics and phosphoproteomics
Mass spectrometry-based proteomics can quantify changes in protein abundance and phosphorylation that accompany inhibition of migration. This is useful to map signaling downstream of semaphorins or JAM-C. Phosphoproteomics can identify kinase substrates that regulate cytoskeletal dynamics.
CRISPR library screening
Genome-wide CRISPR knockout or activation screens can identify novel negative regulators of endothelial cell migration. Cells are subjected to a migration challenge, and enriched sgRNAs reveal candidate genes. This unbiased approach can uncover new therapeutic targets.
How CRISPR Can Be Used to Study GO:0043537 negative regulation of blood vessel endothelial cell migration
Knockout
CRISPR knockout of candidate genes in endothelial cells is used to determine whether they are required for negative regulation of migration. For example, knocking out JAM-C in glioblastoma stem-like cells increased invasion, confirming its inhibitory role. Similarly, knockout of S100P or Ezrin reduces trans-endothelial migration, validating their pro-migratory function. Knockout models are essential for loss-of-function studies.
Point Mutation
Point mutations can be introduced to dissect specific domains or phosphorylation sites. For instance, mutating phosphorylation sites in Ezrin can reveal their importance in migration. Point-mutation knock-in models allow precise testing of causal residues without altering protein levels.
Knock-in
Knock-in of tagged versions of proteins, such as fluorescently labeled JAM-C, enables live imaging of protein localization during migration. Knock-in of inducible overexpression cassettes allows controlled expression of anti-migratory genes like miR-204 in vivo. These models are valuable for studying dynamics and dosage effects.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression can be used to test whether increasing a gene's activity enhances negative regulation. Overexpression of miR-204 in corneal epithelium inhibited neovascularization, demonstrating its therapeutic potential. Overexpression models are useful for gain-of-function studies.
How EDITGENE Supports negative regulation of blood vessel endothelial cell migration Research
Researchers studying negative regulation of blood vessel endothelial cell migration-related genes often need to determine whether a candidate gene is causally involved in inhibiting endothelial cell migration. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this research, from knockout to knock-in and library screening.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of blood vessel endothelial cell migration research.
Frequently Asked Questions About negative regulation of blood vessel endothelial cell migration
What is GO:0043537?
GO:0043537 is the Gene Ontology term for negative regulation of blood vessel endothelial cell migration, defined as any process that stops, prevents, or reduces the frequency, rate, or extent of endothelial cell migration in blood vessels.
What genes are involved in negative regulation of blood vessel endothelial cell migration?
Key genes include SEMA3A, NRP1, PLXNA2, miR-204, S100P, EZR, JAM-C, GATA3, RAMP2, VEGFA, NOTCH1, and DLL4, among others.
How is negative regulation of endothelial cell migration studied?
It is studied using transwell migration assays, scratch-wound assays, live-cell imaging, RNA-seq, proteomics, and CRISPR screens.
What diseases are associated with dysregulated endothelial cell migration?
Cancer metastasis, corneal neovascularization, glioblastoma invasion, and aberrant liver vascular reconstitution are linked to dysregulation of this process.
What is the role of semaphorins in endothelial migration?
Semaphorins act as repulsive guidance cues that inhibit endothelial cell migration through neuropilin and plexin receptors.
How does miR-204 inhibit corneal neovascularization?
Epithelium-derived miR-204 targets pro-angiogenic factors, thereby reducing endothelial cell migration and vessel growth in the cornea.
What is the function of JAM-C in glioblastoma invasion?
JAM-C limits glioblastoma stem-like cell invasion by regulating integrin adhesion at the endothelial interface.
Can CRISPR be used to study negative regulators of endothelial migration?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to test the causal role of candidate genes.
What is the balance between GATA3 and RAMP2 in liver regeneration?
GATA3 and RAMP2 in hepatocytes balance hepatic vascular reconstitution after partial hepatectomy, influencing endothelial migration.
How do S100P and Ezrin promote cancer metastasis?
S100P and Ezrin promote trans-endothelial migration of triple-negative breast cancer cells, facilitating extravasation and metastasis.
Conclusion
GO:0043537, negative regulation of blood vessel endothelial cell migration, is a critical biological process that restrains angiogenesis and maintains vascular homeostasis. Its dysregulation contributes to cancer, ocular neovascularization, and aberrant tissue repair. Key regulators such as semaphorins, miR-204, JAM-C, and the GATA3/RAMP2 axis provide promising targets for therapeutic intervention. Advances in CRISPR-based models and multi-omics approaches are accelerating the discovery of new negative regulators and their mechanisms. EDITGENE offers comprehensive services to support this research, from knockout to library screening, empowering scientists to translate these findings into clinical applications.
References
- 1. Bussolino F et al.. 2006. Semaphoring vascular morphogenesis.. Endothelium 13(2):81-91 PMID: 16728327
- 3. Hirashima M. 2009. Regulation of endothelial cell differentiation and arterial specification by VEGF and Notch signaling.. Anat Sci Int 84(3):95-101 PMID: 19259767
- 4. Wang B et al.. 2024. Balance of Gata3 and Ramp2 in hepatocytes regulates hepatic vascular reconstitution in postoperative liver regeneration.. J Hepatol 80(2):309-321 PMID: 37918568
- 5. Orso F et al.. 2020. Role of miRNAs in tumor and endothelial cell interactions during tumor progression.. Semin Cancer Biol 60:214-224 PMID: 31386907
- 6. Rosińska S et al.. 2025. Junctional adhesion molecule C limits glioblastoma stem-like cell invasion by regulating integrin adhesion at the endothelial interface.. Cell Rep 44(9):116194 PMID: 40875295
- 7. Kikuchi K et al.. 2019. S100P and Ezrin promote trans-endothelial migration of triple negative breast cancer cells.. Cell Oncol (Dordr) 42(1):67-80 PMID: 30244410
- 8. Zhang X et al.. 2018. Epithelium-derived miR-204 inhibits corneal neovascularization.. Exp Eye Res 167:122-127 PMID: 29246498
